Speech-Language Pathologists in Furlong, PA Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Ms. Susan Demilia, MA CCC SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 3814 Forest Hill Dr, Furlong, PA 18925 Phone: 215-794-5869 |
Mary Jean Cooper, MA SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 515 Saint Lawrence Way, Furlong, PA 18925 Phone: 718-494-2141 |
Mrs. Leslie Nastaskin, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3182 Brookside Dr, Furlong, PA 18925 Phone: 267-880-6526 |
News Archive
Macrophages migrate from the blood to attack brain tissue shortly after stroke
Macrophages are part of the innate immune system and essential for brain development and function. Using a novel method, scientists from Jena University Hospital, the University of Bonn and the Memorial Sloan Kettering Cancer Center in New York (USA) succeeded in visualizing macrophages that were formed in the bone marrow.
Canadian coalition prepares to share research that could help against COVID-19
A Canadian group of companies is sharing their results with the scientific community in the hopes of accelerating the development of tests for COVID-19.
Scottish women with metastatic carcinoma of cervix could now benefit from Avastin treatment
From today, women in Scotland with an advanced and incurable form of cervical cancer could benefit from the targeted treatment Avastin, which has been given the green light by the Scottish Medicines Consortium (SMC) for routine use on the NHS.
ISRA sponsors 'Susan G. Komen Shoot for the Cure' event
In observance of National Breast Cancer Awareness Month, the ISRA is pleased to announce its sponsorship of the first annual "Susan G. Komen Shoot for the Cure" benefit shooting event.
Arcadia Capital Advisors files intent to purchase remaining CPEX shares at $14 per share
CPEX Pharmaceuticals, Inc. today confirmed that Arcadia Capital Advisors, LLC and its principal Richard Rofé, who hold approximately 12% of outstanding shares, have filed with the Securities and Exchange Commission (SEC) notice of intention of Mr. Rofé to make an unsolicited contingent offer to purchase the remaining shares of common stock of CPEX for $14.00 per share. Mr. Rofé indicated that any offer would require the CPEX Board of Directors to redeem the Rights under CPEX Shareholder Rights Plan.
› Verified 9 days ago
Chiropractors
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Optometrists